Keyphrases
Atrial Fibrillation Ablation
100%
Tachycardia-induced Cardiomyopathy
100%
Left Ventricular Ejection Fraction
66%
Atrial Fibrillation
33%
Cox-Maze IV
33%
New York Heart Association Functional Classification
33%
Confidence Interval
16%
Consecutive Patients
16%
Left Ventricular Function
16%
Pulmonary Embolism
16%
Echocardiogram
16%
Left Ventricular Dysfunction
16%
Persistent Atrial Fibrillation
16%
30-day Mortality
16%
Patient Demographics
16%
Anticoagulation
16%
Catheter Ablation
16%
Cox-Maze IV Procedure
16%
Antiarrhythmic Drugs
16%
Dilated Cardiomyopathy
16%
Sinus Rhythm
16%
Common Cause
16%
Atrial Tachycardia
16%
Ventricular Function
16%
Atrial Arrhythmia
16%
Sinus Rhythm Restoration
16%
Surgical Ablation
16%
Ischemic Cardiomyopathy
16%
January 2017
16%
Atrial Fibrillation Duration
16%
Medicine and Dentistry
Atrial Fibrillation
100%
Surgical Ablation
100%
Tachycardia-Induced Cardiomyopathy
100%
Heart Left Ventricle Ejection Fraction
66%
Sinus Rhythm
33%
Pulmonary Embolism
16%
Heart Left Ventricle Function
16%
Echocardiography
16%
Persistent Atrial Fibrillation
16%
Antiarrhythmic Agent
16%
Retrospective Study
16%
Anticoagulation
16%
Heart Ventricle Function
16%
Heart Left Ventricle Failure
16%
Patient Population
16%
Dilated Cardiomyopathy
16%
Ischemic Cardiomyopathy
16%
Tachycardia
16%
Biochemistry, Genetics and Molecular Biology
Tachyarrhythmia
100%
Tachycardia
100%
Ablation of Atrial Fibrillation
100%
Heart Left Ventricle Ejection Fraction
66%
Atrial Fibrillation
66%
Heart Ventricle Function
33%
Sinus Rhythm
33%
Heart Left Ventricle Function
16%
Anticoagulation
16%
Retrospective Study
16%
Antiarrhythmic Agent
16%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Tachycardia Induced Cardiomyopathy
100%
Heart Left Ventricle Failure
16%
Antiarrhythmic Agent
16%
Retrospective Study
16%
Lung Embolism
16%
Congestive Cardiomyopathy
16%
Ischemic Cardiomyopathy
16%
Persistent Atrial Fibrillation
16%